Open Access

Individual decision for length of dual antiplatelet therapy after ACS.

Congress Session

About the speaker

Professor Peter Michael Clemmensen

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
9 presentations
0 follower

3 more presentations in this session

Distribution of estimated 10-year risk of recurrent vascular events and residual risk in a secondary prevention population.

Speaker: Professor F. Visseren (Utrecht, NL)


New antidiabetic agents reduce cardiovascular events.

Speaker: Professor J. Schmid (Gais, CH)


PCSK9-Inhibitions: for whom, when, and how effective.

Speaker: Professor C. Saely (Feldkirch, AT)


Access the full session

Secondary Prevention: unmet medical needs - Session I

Speakers: Professor P. Clemmensen, Professor F. Visseren, Professor J. Schmid, Professor C. Saely

About the event


EuroPrevent 2017

6 April - 8 April 2017

Sessions Presentations

This platform is supported by

logo Novo Nordisk